National Account Director, Academic/IDN Oncology

National Account Director, Academic/IDN OncologyRevolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.The Opportunity:Reporting directly to the Senior Director, Provider Accounts, the National Account Director, Academic/IDN Oncology is responsible for establishing and maintaining strategic relationships to secure optimal market access for our innovative oncology medicines within Large Health Systems, Integrated Delivery Networks (IDNs), KOL stakeholders and institution specific clinical pathways. The NAD will develop and execute account plans and strategies that drive rapid pathway and protocol inclusions to support rapid access while representing the company's interests with key decision-makers. The NAD will help to coordinate cross-functional workstreams to ensure products are included when appropriate in institution-driven clinical pathways. This is a field-based remote position.Key Responsibilities:Translate national, brand-level strategy to targeted Large Health Systems, IDNs and key KOL/Pharmacy decision makers.Lead and oversee account activities such as driving rapid formulary, clinical pathway and treatment protocol inclusion post launch in close collaboration with Medical Affairs.Lead all Business to Business and C-Suite relationships with key accounts to support speaker programs, access activities, networking events, and company partnerships.Build and maintain strong KOL and C-level relationships with aligned IDN and large system accounts.Lead cross-functional team across Commercial Field to pro-actively identify and resolve access barrier issues.Analyze business opportunities to proactively provide strategic and tactical guidance.Negotiate favorable contracts and agreements.Create medium to long term strategic engagement plan spanning multiple product and indication launches and focuses on engaging beyond transactional approaches.Facilitate executive exchanges to create opportunities for Rev Med leaders and IDN/C-Suite leaders to meet and align.Identify the overlap between customer needs and Rev Med needs to build collaborative business solutions.Champion voice of customer to internal stakeholders and commercial leadership.Consistently strong appropriate engagement with IDN pharmacy leadership and formulary decision makers.Provide strategic insights and feedback to brands, field, and market access.Quickly communicate when important opportunities arise.Activate resources to support opportunities and challenges.Ability to design and lead pull through projects with commercial field.Conduct quarterly business reviews with key systems and internal stakeholders.Track and analyze account performance and identify areas for improvement.Required Skills, Experience and Education:Bachelor's degree and 10+ years strategic account management experience.Strong established relationships within IDN/Academic Centers, Pharmacy, C-suite and Key KOL stakeholders.Demonstrated understanding of reimbursement, economic flows, and oral oncolytic trends within health systems and key customer stakeholders.Strong communication skills to educate and influence other stakeholders, including the commercial executive leadership team and US Market Access.Ability to clearly and efficiently communicate the value proposition of novel oncology therapies to customers.Excellent negotiation skills and pride in P&L and enterprise stewardship.Prior experience with pipeline products and product launches.Ability to partner effectively with Medical Affairs, Sales, Marketing and FRM teams.Strategic account planning and strong business acumen.50% travel required to customer meetings, industry conferences, and Rev Med's home office in Redwood City, CA.Preferred Skills:Advanced degree (MBA, Master's, PharmD, PhD).Existing relationships within the IDN/ academic oncology segment and key pharmacy/ KOLs stakeholders within the segment.Comprehensive experience and understanding Large Health Systems/IDNs and the Hospital class of trade.Experience in GI oncology, PDAC and/or NSCLC, including oral targeted therapies.Successful coordination of leadership exchanges and strategic partnerships beyond traditional contracting and rebate agreements.Previous direct experience with contract negotiation, implementation and pull through.Desire to continuously learn, develop, and stay abreast of the evolving healthcare landscape.Passion for establishing high-functioning, collaborative relationships with new and rapidly growing teams.Prior people leadership experience and ability to build team as company grows.